Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

10.40
Delayed Data
As of May 29
 +0.21 / +2.06%
Today’s Change
8.84
Today|||52-Week Range
18.48
-26.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues0.00256.0K569.0K1.2M
 
 
 
 
Cost of Goods Sold0.0057.0K220.0K528.0K
 
 
 
 
Depreciation And Amortization56.0K97.0K121.0K--
 
 
 
 
 
Operating ExpensesGross Income-56.0K102.0K228.0K647.0K
 
 
 
 
 
General Expenses22.5M35.5M39.9M28.5M
 
 
 
 
 
Research And Development10.3M19.1M5.8M9.6M
 
 
 
 
 
Total Operating Expenses22.5M35.7M40.2M29.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-22.5M-35.4M-39.6M-27.8M
 
 
 
 
 
Other Expenses0.000.0052.0K--
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-22.4M-35.3M-39.6M-27.7M
 
 
 
 
 
Income Taxes0.000.00-700.0K-22.0K
 
 
 
Net Income-22.4M-35.3M-40.3M-27.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS91.5M91.8M92.1M100.6M
 
 
 
 
 
Shares To Calculate EPS Diluted91.5M91.8M92.1M100.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.24-$0.38-$0.44-$0.28
 
 
 
 
 
EPS Diluted-$0.24-$0.38-$0.44-$0.28
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account